Discover 625 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Arkansas offers a variety of research opportunities for both healthy volunteers interested in paid clinical studies and individuals seeking trials for specific health conditions. Major research centers in Little Rock, Fayetteville, and Fort Smith are actively recruiting participants, providing access to advanced treatments and innovative medical care.
Filter
1
Filter results
Results: 625
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
for
Gout
Location: Suffolk VA, Duncansville PA, Hialeah FL, Miami FL,
Sponsor: Protalix
Sex: All
Age: 18+
Code: NCT07280156
Phase 2, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Sparta NJ, Marlton NJ, Greenbelt MD, Richmond VA,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase 2, Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
for
Major Depressive Disorder (MDD)
Location: Watertown MA, New York NY, Marlton NJ, Gaithersburg MD,
Sponsor: Draig Therapeutics Ltd
Sex: All
Age: 18 - 70+
Code: NCT07300969
Phase 2, Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07226427
Phase 1, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: New York NY, Clifton NJ, Wilmington NC, Boca Raton FL,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07690371
Phase 3, Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
for
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1,
Location: New York NY, Montreal, Hershey PA, Chevy Chase MD,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06960213
Phase 3, Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis